RNXT - RenovoRx, Inc.
1.055
0.025 2.370%
Share volume: 63,021
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.02
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-13-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 2.476 M | 3.034 M | 2.828 M | |
| Selling general and admin | 1.219 M | 1.492 M | 1.178 M | |
| Research and development | 1.257 M | 1.542 M | 1.650 M | |
| Total expenses | 2.476 M | 3.034 M | 2.828 M | |
| 22.54% | -6.79% | |||
| Operating income | -2.476 M | -3.034 M | -2.828 M | |
| Ebit | -1.113 M | -2.527 M | -2.595 M | |
| Pretax income | -1.076 M | -2.389 M | -2.471 M | |
| 122.03% | 3.43% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.076 M | -2.389 M | -2.471 M | |
| -122.03% | -3.43% |
